CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jan 7, 2016 · 10-K · 129 days after period end · 0001019687-16-004727
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$204.54K | -$168.62K | -$31.91K | $14.44K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Aug 31, 2015 · filed Jan 7, 2016 · 129 d after period end
